FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Mann Michael Scott 		2. Issuer Name and Ticker or Trading Symbol

ENDONOVO THERAPEUTICS, INC. [ ENDV ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
President
(Last)          (First)          (Middle)

6320 CANOGA AVENUE 		3. Date of Earliest Transaction (MM/DD/YYYY)

4/25/2017
(Street)

WOODLAND HILLS, CA 91367
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   4/25/2017     P    1000   A $0.068   20336949   D    
Common Stock   4/25/2017     P    1000   A $0.068   20337949   D    
Common Stock   4/25/2017     P    1000   A $0.068   20338949   D    
Common Stock   4/25/2017     P    1000   A $0.068   20339949   D    
Common Stock   4/25/2017     P    1000   A $0.071   20340949   D    
Common Stock   4/25/2017     P    1000   A $0.071   20341949   D    
Common Stock   4/25/2017     P    1000   A $0.0714   20342949   D    
Common Stock   4/25/2017     P    1000   A $0.0714   20343949   D    
Common Stock   4/25/2017     P    1000   A $0.072   20344949   D    
Common Stock   4/25/2017     P    1000   A $0.0739   20345949   D    
Common Stock   4/25/2017     P    1000   A $0.0739   20346949   D    
Common Stock   4/25/2017     P    1000   A $0.074   20347949   D    
Common Stock   4/25/2017     P    1000   A $0.074   20348949   D    
Common Stock   4/25/2017     P    1000   A $0.074   20349949   D    
Common Stock   4/25/2017     P    1000   A $0.073   20350949   D    
Common Stock   4/25/2017     P    1000   A $0.07   20351949   D    
Common Stock   4/25/2017     P    1000   A $0.073   20352949   D    
Common Stock   4/25/2017     P    1000   A $0.072   20353949   D    
Common Stock   4/25/2017     P    1000   A $0.073   20354949   D    
Common Stock   4/25/2017     P    1000   A $0.0729   20355949   D    
Common Stock   4/25/2017     P    1000   A $0.073   20356949   D    
Common Stock   4/25/2017     P    1000   A $0.0729   20357949   D    
Common Stock   4/25/2017     P    1000   A $0.073   20358949   D    
Common Stock   4/25/2017     P    1000   A $0.073   20359949   D    
Common Stock   4/25/2017     P    1000   A $0.073   20360949   D    
Common Stock   4/25/2017     P    1000   A $0.073   20361949   D    
Common Stock   4/25/2017     P    1000   A $0.073   20362949   D    
Common Stock   4/25/2017     P    1000   A $0.073   20363949   D    
Common Stock   4/25/2017     P    1000   A $0.0727   20364949   D    
Common Stock   4/25/2017     P    1000   A $0.0701   20365949   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Mann Michael Scott
6320 CANOGA AVENUE
WOODLAND HILLS, CA 91367
X President

Signatures
Michael Mann 4/27/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.